Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
World J Pediatr Congenit Heart Surg ; : 21501351241247513, 2024 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-38751076

RESUMO

Obstructed infracardiac total anomalous pulmonary venous return is nearly always a surgical emergency in which infants present in severe cardiopulmonary distress. Ductal venosus stenting can provide a temporizing option for premature, low birth weight infants with high risk for surgical complications. In challenging anatomic cases, virtual reality, 3D-printed models, and fusion image guidance can aid in procedural planning and provide support for successful intervention.

2.
Pediatr Cardiol ; 2024 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-38489092

RESUMO

For congenital heart disease patients, multiple imaging modalities are needed to discern anatomy and functional information such as differential blood flow. During cardiac catheterization, 3D rotational angiography (3DRA) can provide CTA-like images, enabling anatomical information and intraprocedural guidance. We seek to establish whether unique aspects of this technique can also generate quantitative functional blood flow information. We propose that systematic integration of 3DRA imaging, catheter hemodynamic information, and computational fluid dynamics (CFD), can provide quantitative information regarding blood flow dynamics and energetics, without additional imaging or procedures. We report a single center retrospective feasibility study comprising four patients with 3DRA imaging and a complete set of hemodynamic data. 3DRA was processed and segmented to reconstruct vascular regions of interest (ROI), and a computational grid for CFD modeling of blood flow through the ROI was generated. Blood flow was simulated by integrating catheter hemodynamic data to devise boundary conditions at vascular ROI inlets and outlets. The 3DRA-based workflow successfully generated key computational outputs commonly used for cardiovascular applications, including flow patterns, distribution fractions, wall shear stress. Computational outputs obtained were as detailed and resolved as those obtained from more commonly used CT or MR angiography. Accuracy was confirmed by comparing computed flow distributions with measurements for 2 cases, showing less than 2.0% error from the measured data. Systematic integration of catheter hemodynamic information, 3DRA imaging, and CFD modeling, provides an effective and feasible alternative to obtain important quantitative blood flow information and visualization, without additional imaging.

3.
Pediatr Cardiol ; 44(5): 1125-1134, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36723625

RESUMO

BACKGROUND: Pulmonary vein stenosis (PVS) is a growing problem for the pediatric congenital heart population. Sirolimus has previously been shown to improve survival and slow down the progression of in-stent stenosis in patients with PVS. We evaluated patients before and after initiation of sirolimus to evaluate its effects on re-intervention and vessel patency utilizing Optical Coherence Tomography (OCT). METHODS: We performed a retrospective study, reviewing the charts of patients with PVS, who had been prescribed sirolimus between October 2020 and December 2021. OCT was performed in the pulmonary vein of interest as per our published protocol. Angiographic and OCT imaging was retrospectively reviewed. Statistical analysis was performed using Chi square and Wilcoxon signed-rank test to compare pre-and post-sirolimus data. RESULTS: Ten patients had been started and followed on sirolimus. Median age at sirolimus initiation was 25 months with median weight of 10.6 kg and average follow-up of 1 year. Median total catheterizations were 7 for patients prior to starting sirolimus and 2 after starting treatment (p = 0.014). Comparing pre- and post-sirolimus, patients were catheterized every 3 months vs every 11 months (p = 0.011), median procedure time was 203 min vs 145 min (p = 0.036) and fluoroscopy time, 80 min vs 57.2 min (p = 0.036). 23 veins had severe in-stent tissue ingrowth prior to SST (luminal diameter < 30% of stent diameter). Post-sirolimus, 23 pulmonary veins had moderate to severe in-stent tissue ingrowth that responded to non-compliant balloon inflation only with stent luminal improvement of > 75%. CONCLUSION: Our study suggests that the addition of sirolimus in patients with moderate-severe PVS helps to decrease disease progression with decrease frequency of interventions. Reaching therapeutic levels for sirolimus is critical and medication interactions and side-effects need careful consideration. OCT continues to be important for evaluation and treatment guidance in this patient population.


Assuntos
Fármacos Cardiovasculares , Hipertensão Pulmonar , Intervenção Coronária Percutânea , Estenose de Veia Pulmonar , Criança , Humanos , Estenose de Veia Pulmonar/diagnóstico por imagem , Estenose de Veia Pulmonar/terapia , Sirolimo , Tomografia de Coerência Óptica , Estudos Retrospectivos , Altitude , Resultado do Tratamento , Vasos Coronários
4.
J Cardiol Cases ; 25(4): 229-233, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35911065

RESUMO

A 25-year-old male presented to our institution with acute right ventricular (RV) failure secondary to an infected pulmonary prosthetic valve (Melody® Valve, Medtronic Inc., Minneapolis, MN, USA), 3 months after percutaneous placement. Due to his decompensated state, his surgical risk was determined to be very high during his acute illness. As a bridge to surgical valve replacement, we elected to percutaneously implant a Sapien S3 valve (Edwards Lifesciences, Irvine, CA, USA), mounted within a covered stent and deployed simultaneously to exclude the mass of infected tissue within the RV outflow tract, and improve his hemodynamics. Our patient tolerated the procedure well; recovered fully and returned 2 months later for planned surgical valve replacement. .

5.
BMC Musculoskelet Disord ; 17: 127, 2016 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-26979873

RESUMO

BACKGROUND: We evaluated effects of botulinum toxin A (Botox) and cast immobilization on tendon healing in a rat model. Injection of Botox into rat supraspinatus was hypothesized to reduce muscle active force and improved healing. METHODS: Eighty-four supraspinatus tendons were surgically transected and repaired in 42 Sprague-Dawley rats (transosseous technique). After repair, supraspinatus muscle was injected with saline or Botox (3 or 6 U/kg). Half the shoulders were cast-immobilized for the entire postoperative period; half were allowed free cage activity. Histology was examined at 2, 4, 8, and 12 weeks. A healing zone cross-sectional area was measured, and biomechanical testing of repair strength and tendon viscoelastic properties was conducted at 4 and 12 weeks. RESULTS: Botox alone and cast immobilization alone exhibited increased ultimate load compared with controls (saline injection, no immobilization) at 4 weeks. No difference in ultimate load occurred between Botox-only and cast-only groups. At 12 weeks, the Botox (6 U/kg) plus cast immobilization group was significantly weakest (p < 0.05). A trend was shown toward decreased healing zone cross-sectional areas in casted groups. CONCLUSIONS: Supraspinatus Botox injection after rotator cuff repair might help protect the repair. However, cast immobilization plus Botox administration is harmful to rotator cuff healing in a rat tendon model.


Assuntos
Inibidores da Liberação da Acetilcolina/farmacologia , Toxinas Botulínicas Tipo A/farmacologia , Restrição Física , Manguito Rotador/efeitos dos fármacos , Traumatismos dos Tendões/terapia , Cicatrização/efeitos dos fármacos , Animais , Modelos Animais de Doenças , Masculino , Ratos Sprague-Dawley , Manguito Rotador/patologia , Manguito Rotador/fisiopatologia , Manguito Rotador/cirurgia , Traumatismos dos Tendões/tratamento farmacológico , Traumatismos dos Tendões/patologia , Traumatismos dos Tendões/fisiopatologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...